Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,754 | N/A | -21,682 | -2,003 | 1,429 |
| Depreciation Amortization | 22 | N/A | N/A | N/A | N/A |
| Accounts receivable | 600 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 83 | N/A | 1,602 | 90 | 2 |
| Other Working Capital | -387 | N/A | 1,171 | 206 | 54 |
| Other Operating Activity | 3,241 | 0 | 6,035 | 1,300 | -1,717 |
| Operating Cash Flow | $-6,195 | $N/A | $-12,874 | $-407 | $-233 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -960 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 108 | 77 |
| Investing Cash Flow | $-960 | $N/A | $N/A | $108 | $77 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 10,750 | 0 | 484 | 0 | 0 |
| Financing Cash Flow | $10,752 | $N/A | $484 | $N/A | $N/A |
| Beginning Cash Position | 20,183 | N/A | 27,163 | 1,213 | 1,213 |
| End Cash Position | 23,780 | N/A | 14,773 | 914 | 1,057 |
| Net Cash Flow | $3,597 | $N/A | $-12,390 | $-299 | $-156 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,195 | N/A | -12,874 | -407 | -233 |
| Capital Expenditure | -960 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,155 | 0 | -12,874 | -407 | -233 |